SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly: the Framingham Osteoarthritis Study. Arthritis Rheum 1987; 30: 9148.
  • 2
    Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum 2008; 59: 120713.
  • 3
    Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Ann Intern Med 2000; 137: 2217.
  • 4
    Hart DJ, Spector TD. The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study. J Rheumatol 1993; 20: 3315.
  • 5
    Cicuttini FM, Baker JR, Spector TD. The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 1996; 23: 12216.
  • 6
    Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman B, Aliabadi P, et al. Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum 1997; 40: 72833.
  • 7
    Davis MA, Ettinger WH, Neuhaus JM, Mallon KP. Knee osteoarthritis and physical functioning: evidence from the NHANES1 Epidemiologic Follow-up Study. J Rheumatol 1991; 18: 5918.
  • 8
    Elder SH, Kimura JH, Soslowsky LJ, Lavagnino M, Goldstein S. Effect of compressive loading on chondrocyte differentiation in agarose cultures of chick limb-bud cells. J Orthopaed Res 2000; 18: 7886.
  • 9
    Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage 2002; 10: 595601.
  • 10
    Hart DJ, Doyle DV, Spector TD. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol 1995; 22: 111823.
  • 11
    Acheson RM, Collart AB. New Haven survey of joint diseases. XVII. Relationship between some systemic characteristics and osteoarthritis in a general population. Ann Rheum Dis 1975; 34: 37987.
  • 12
    Davis MA, Ettinger WH, Neuhaus JM. The role of metabolic factors and blood pressure in the association of obesity with osteoarthritis of the knee. J Rheumatol 1988; 15: 182732.
  • 13
    Anderson JJ, Felson DT. Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I): evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol 1988; 128: 17989.
  • 14
    Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997; 40: 7237.
  • 15
    Sharif M, Shepstone L, Elson CJ, Dieppe PA, Kirwan JR. Increased serum C-reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis 2000; 59: 714.
  • 16
    Engstrom G, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Lohmander LS. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis: a population-based cohort study. Osteoarthritis Cartilage 2009; 17: 16873.
  • 17
    Kraus VB, Stabler TV, Luta G, Renner JB, Dragomir AD, Jordan JM. Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis. Osteoarthritis Cartilage 2007; 15: 96671.
  • 18
    Dahaghin S, Bierma-Zeinstra SM, Koes BW, Hazes JM, Pols HA. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis 2007; 66: 91620.
  • 19
    Brouwer GM, van Tol AW, Bergink AP, Belo JN, Bernsen RM, Reijman M, et al. Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum 2007; 56: 120411.
  • 20
    Cahue S, Dunlop D, Hayes K, Song J, Torres L, Sharma L. Varus–valgus alignment in the progression of patellofemoral osteoarthritis. Arthritis Rheum 2004; 50: 218490.
  • 21
    Kobayashi T, Yoshihara Y, Yamada H, Fujikawa K. Procollagen IIC-peptide as a marker for assessing mechanical risk factors of knee osteoarthritis: effect of obesity and varus alignment. Ann Rheum Dis 2000; 59: 9824.
  • 22
    Andriacchi TP, Mundermann A. The role of ambulatory mechanics in the initiation and progression of knee osteoarthritis. Curr Opin Rheumatol 2006; 18: 5148.
  • 23
    Buckland-Wright C. Protocols for precise radio-anatomical positioning of the tibiofemoral and patellofemoral compartments of the knee. Osteoarthritis Cartilage 1995; 3 Suppl A: 7180.
  • 24
    Kellgren JH, Lawrence JS. The epidemiology of chronic rheumatism. Vol. II. Atlas of standard radiographs of arthritis. Philadelphia: FA Davis; 1963.
  • 25
    Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 26
    Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Underwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 1992; 305: 1604.
  • 27
    McHorney CA, Ware JE, Raczek AE. The MOS 36-item short form health survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 24763.
  • 28
    McHorney CA, Ware JE, Lu RJ, Sherbourne CE. The MOS 36-item short for health survey (SF-36). III. Tests of data quality, scaling, assumption and reliability among diverse patient groups. Med Care 1994; 32: 4066.
  • 29
    Nagi SZ. An epidemiology of disability among adults in the United States. Milbank Mem Fund Q Health Soc 1976; 54: 43967.
  • 30
    Warnick GR, Albers JJ. A comprehensive evaluation of heparin-manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J Lipid Res 1978; 19: 6576.
  • 31
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499502.
  • 32
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27 Suppl 1: S510.
  • 33
    Michos ED, Blumenthal RS. Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the US: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin) study. J Am Coll Cardiol 2009; 53: 9315.
  • 34
    Ridker PM, Danielson E, Fonesca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195207.
  • 35
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 248697.
  • 36
    World Health Organization. Obesity: preventing and managing the global epidemic. Geneva (Switzerland): WHO; 2000.
  • 37
    Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometaboilc risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 2008; 16B: 161724.
  • 38
    Wildman RP, Mancuso P, Wang C, Kim M, Scherer PE, Sowers MR. Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: longitudinal associations. Int J Obes (Lond) 2008; 32: 7408.
  • 39
    Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 145562.
  • 40
    Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unravelling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1998; 1: 44550.
  • 41
    Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P, et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003; 48: 311829.
  • 42
    Kume K, Satomura K, Nishisho S, Kitaoka E, Yamanouchi K, Tobiume S, et al. Potential role of leptin in endochondral ossification. J Histochem Cytochem 2002; 50: 15969.
  • 43
    Figenschau Y, Knutsen G, Shahazcydi S, Johansen O, Sveinbjornson B. Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun 2001; 287: 1907.
  • 44
    Scharstuhl A, Glansbeck HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB. Inhibition of endogenous TGF-b during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 2002; 169: 50714.
  • 45
    Glansbeck GL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB. Stimulation of articular cartilage repair in established arthritis by local administration of transporting growth factor-β into murine knee joints. Lab Invest 1998; 78: 13342.
  • 46
    Grimaud E, Heymann D, Redini F. Recent advances in TGF-β effects on chondrocyte metabolism: potential therapeutic roles of TGF-β in cartilage disorders. Cytokine Growth Factor Rev 2002; 13: 24157.
  • 47
    Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 9119.
  • 48
    Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci 2006; 110: 26778.
  • 49
    Chen TH, Chen L, Hsieh MS, Chang CP, Chou DT, Tsai SH. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta 2006; 1762: 7118.
  • 50
    Schaffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Scholmerich J, et al. Adipocytokines in synovial fluid [letter]. JAMA 2003; 290: 170910.
  • 51
    Gegout PP, Francin PJ, Mainard D, Presle N. Adipokines in osteoarthritis: friends or foes of cartilage homeostasis? Joint Bone Spine 2008; 75: 66971.
  • 52
    Presle N, Pottie P, Dumond H, Guillaume C, Lapicque F, Pallu S, et al. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis: contribution of joint tissues to their articular production. Osteoarthritis Cartilage 2006; 14: 6905.
  • 53
    Lago R, Gomez R, Otero M, Lago F, Gallego R, Dieguez C, et al. A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage 2008; 16: 11019.
  • 54
    Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kB pathway. J Immunol 2007; 179: 548392.
  • 55
    Ehling A, Schaffler A, Herfarth H, Tarner IH, Anders S, Distler O, et al. The potential of adiponectin in driving arthritis. J Immunol 2006; 176: 446878.
  • 56
    Wearing SC, Henning EM, Bryne NM, Steele JR, Hills AP. Musculoskeletal disorders associated with obesity: a biomechanical perspective. Obes Rev 2006; 7: 23950.
  • 57
    Messier SP, Ettinger WH, Doyle TE, Morgan T, James MK, O'Toole ML, et al. Obesity: effects on gait in an osteoarthritic population. J Appl Biomech 1996; 12: 16172.
  • 58
    Browning RC, Kram R. Effects of obesity on the biomechanics of walking at different speeds. Med Sci Sports Exerc 2007; 9: 163241.
  • 59
    Sharma L, Lou C, Cahue S, Dunlop DD. The mechanism of the effect of obesity in knee osteoarthritis: the mediating role of malalignment. Arthritis Rheum 2000; 43: 56875.